Quick Answer
NEKTAR THERAPEUTICS reported Revenue From Contract With Customer Excluding Assessed Tax of $55.23 million for the year ending 2025.
- NEKTAR THERAPEUTICS showed a decrease of -43.9% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from NEKTAR THERAPEUTICS's annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), NEKTAR THERAPEUTICS's Revenue From Contract With Customer Excluding Assessed Tax has declined by 66.6%.
- Historical annual values: Fiscal year 2025: $55.23 million | Fiscal year 2024: $98.43 million | Fiscal year 2023: $90.12 million | Fiscal year 2022: $92.06 million | Fiscal year 2021: $101.91 million | Fiscal year 2020: $152.92 million | Fiscal year 2019: $114.62 million | Fiscal year 2018: $1.19 billion | Fiscal year 2017: $307.71 million | Fiscal year 2016: $165.44 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: